25 May 2013
Keywords: vivus, returns, profit, evamist, gain, company, second-quarter
Article | 01 September 2008
US company Vivus' second-quarter results showed a return to profit after last year's loss on an over five-times-higher revenue almost ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 September 2008
24 May 2013
© 2013 thepharmaletter.com